Abstract: The primary function attributed to the activity profile of the peptide BPC-157 is its regenerative effect. It enables effective peptide therapy in cases of injuries and disorders of the musculoskeletal system, such as fractures, dislocations, or sprains, as well as in the regeneration of muscular injuries, including muscle tears.
Keywords: BPC-157; skeletal system; bones; skeleton; muscular system; muscles; tendons; joints; fracture; injury; therapy; collagen; cartilage; study; control group; peptide; Achilles tendon; experiment; swelling; pain; trauma; regeneration; reconstruction; surgery; procedure; burns; cuts
List of abbreviations: BPC-157-Body Protection Compound
Material and research methods: The studies were conducted on laboratory animals, including male and female albino rats and rabbits.
Skeletal system
Structure of the skeletal system For reference, let us recall the structure of the skeletal system, which consists mainly of bone tissue and cartilage tissue. This system is composed of approximately 206 bones, including long, short, flat, and irregular bones. The human skeleton can be divided into the axial skeleton and the appendicular skeleton with girdles. (Fig.1) The presented structure of the skeletal system will allow us to better understand and visualize the effect of BPC-157 on its functioning.

Figure 1. Illustrative presentation of the structure of the musculoskeletal system
Functions of the skeletal system
The primary and widely known function of the skeletal system is to form a specific framework for our body, ensuring an upright posture and protecting all internal organs. Additionally, the system provides support for the muscles, with which it cooperates to form the locomotor system.
Muscular system
Structure of the muscular system The cell types that make up the muscular system include striated skeletal muscle cells, cardiac striated muscle cells, and smooth muscle cells without striations. Additionally, skeletal muscles are composed of myocytes or muscle fibers consisting of myofibrils. Considering the morphological structure of the muscular system, the following can be distinguished: the muscle belly composed of muscle fibers, the initial and terminal tendon, and the origin and insertion. An illustrative presentation of the muscular system structure allows for a better understanding of peptide BPC-157 therapy on this system.
Functions of the muscular system
The functions of the muscular system include enabling movement while performing precise motions. Its proper functioning makes it possible to maintain correct body posture and keep internal organs in a specific, stable position. Injuries and dysfunctions of the musculoskeletal system, muscles, and tendons, which are affected by BPC-157 therapeutic therapy Musculoskeletal injuries Any physical activity, especially in the world of sports and excessive physical exertion, may result in bone or joint injury. Musculoskeletal injuries include fractures, dislocations, and sprains. Each injury is accompanied by increasing pain, swelling, bruising, and limited mobility, which is why rapid and effective therapy is so important to restore freedom of movement and quality of life. One therapy helpful in such injuries is peptide BPC-157 therapy.
Muscle and joint injuries
Peptide BPC-157 is primarily recognized for its regenerative function; therefore, it is used in muscle and tendon injuries. As with musculoskeletal injuries, these injuries occur mostly in athletes, with muscle strain being the most common condition. Such injuries are accompanied by pain and the inability to return to training or competition. Proper diagnosis and therapy can optimize the injury and accelerate recovery. These therapies also include peptide BPC-157 therapy.
BPC-157 therapeutic therapy for selected musculoskeletal, muscle, and tendon injuries in relation to research
- Bone fracture
Bone fractures most commonly occur as a result of trauma but may also arise due to weakened bone structure during disease processes, including infections or hereditary diseases. Almost any bone can fracture, and the most dangerous type is a compression fracture of the vertebrae. Symptoms accompanying a fracture include pain, inability to move, swelling, and edema.
a. BPC-157 therapy Peptide BPC-157 allows for a twofold faster union of a fractured bone. Fibroblasts formed at the fracture site, which create a scaffold structure composed of calcium, cartilage, and collagen, develop more rapidly in the presence of the peptide. During bone healing, new tissue is characterized by high fragility and delicacy; BPC-157 supports this process, leading to greater strength and hardness of the tissue and, consequently, faster regeneration and bone union.
b. Conducted experimental studies
Study 1
Material Male rabbits subjected to appropriate preoperative nutrition.
Study course On the left forelimbs of rabbits, under deep anesthesia, an incision was made on the surface of the radial shaft. The wound was rinsed with saline solution and closed. To obtain and compare results, an X-ray of the injured limb was performed immediately after the procedure. The limb was then immobilized with a plaster splint. The rabbits were administered an antibiotic. Some rabbits were assigned to the control group, while the second group received intramuscular injections of peptide BPC-157 at a dose of 10 mg/kg body weight. Results were presented based on X-ray images taken after healing. Non-decalcified, isolated bone specimens were observed under a microscope to analyze the damage. Results The surface area of the callus formed during bone healing in the group treated with peptide BPC-157 was twice as large as in the control group during the same recovery period.
Conclusions In the case of bone fractures, therapy with peptide BPC-157 is a highly effective method. The peptide accelerates the healing of fractures as well as various bone defects and deficiencies. It should be noted that this therapy enables the achievement of bone union while simultaneously making the bones stronger and less susceptible to future injuries.






BPC-157 in the gastrointestinal tract. Cytoprotective effects of BPC-157 in diseases of the stomach, intestines, and liver.
BPC-157 Therapy in the Cardiovascular System. Cardioprotective Effects of the Peptide and Its Application in Metabolic Diseases.